Oramed Pharmaceuticals
ORMP
ORMP
56 hedge funds and large institutions have $12.1M invested in Oramed Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
–
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
17
Reduced
11
Closed
9
Calls
$136K
Puts
$52K
Net Calls
+$84K
Net Calls Change
+$1K
Top Buyers
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
GCP
2
GSA Capital Partners
London,
United Kingdom
|
$0 |
| 3 |
3
Citigroup
New York
|
$0 |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$0 |
| 5 |
VF
5
Virtu Financial
New York
|
$0 |
